Farallon Capital Management, L.l.c.
Farallon Capital Management, L.l.c. reported 82 US-listed holdings worth $16.94 billion in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Revolution Medicines, Inc. (15.0%), Electronic Arts Inc (9.6%) and Bridgebio Pharma Inc. (4.7%). Against the quarter before, it opened 18 positions, added to 28, trimmed 23 and sold out of 104.
Filed before as Farallon Capital Management LLC.
Reported holdings$16.94B+0.9% on Q1 2026
Positions82-86 on Q1 2026
The largest ten56.2%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Added toHeldTrimmed
The 14 largest of its 82 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 18Added 28Held 13Trimmed 23Sold out 104
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 18
- Parabilis Medicines Inc. Com PBLS$64.8 million
- Novartis AG NVS$56.9 million
- Warby Parker Inc. WRBY$25.1 million
- Kailera Therapeutics Inc. KLRA$24.2 million
- Axalta Coating Systems Ltd. AXTA$16.4 million
- Biogen Inc. BIIB$15.3 million
- Taysha Gene Therapies Inc. TSHA$15.3 million
- Mobia Med Inc. MOBI$15.1 million
and 10 more in the table below
Added to 28
- Immunovant Inc. IMVT+4.3 million shares · +275%
- Roivant Sciences Ltd. ROIV+4.6 million shares · +48%
- Boston Scientific Corp. BSX+3.1 million shares · +41%
- Bridgebio Pharma Inc. BBIO+1.4 million shares · +15%
- Tango Therapeutics Inc. TNGX+3.2 million shares · +35%
- Electronic Arts Inc EA+449,500 shares · +6%
- Novo Nordisk A/S NVO+1.8 million shares · +235%
- Baidu, Inc. BIDU+760,000 shares · +171%
and 20 more in the table below
Trimmed 23
- Microsoft Corp. MSFT-1.2 million shares · -53%
- Amazon.com Inc. AMZN-1.6 million shares · -38%
- Aon plc AON-1.1 million shares · -45%
- Natera Inc Com NTRA-989,000 shares · -31%
- Broadcom Inc. AVGO-627,700 shares · -35%
- UnitedHealth Group Inc. UNH-551,174 shares · -30%
- Westinghouse Air Brake Technologies Corp. WAB-714,900 shares · -44%
- Synopsys Inc. SNPS-383,700 shares · -32%
and 15 more in the table below
Sold out of 104
- Charles Schwab Corp. SCHW$371.8 million last quarter
- Alphabet Inc. GOOG$285.8 million last quarter
- Visa Inc. V$254.1 million last quarter
- Walt Disney Co. DIS$231.5 million last quarter
- Mastercard Inc. MA$217.4 million last quarter
- McKesson Corp. MCK$202.8 million last quarter
- Centessa Pharmaceuticals PLC CNTA$191.0 million last quarter
- Tyra Biosciences Inc. TYRA$137.1 million last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Revolution Medicines, Inc. RVMD | 13,550,796 | $2.54 billion | 14.98% | -54,000 |
| Electronic Arts Inc EA | 7,919,500 | $1.62 billion | 9.58% | +449,500 |
| Bridgebio Pharma Inc. BBIO | 10,743,063 | $800.1 million | 4.72% | +1,377,600 |
| Protagonist Therapeutics, Inc. PTGX | 6,348,906 | $778.2 million | 4.59% | no change |
| Exelixis, Inc. EXEL | 13,468,010 | $732.8 million | 4.32% | +357,000 |
| Liquidia Corp. LQDA | 8,365,038 | $666.9 million | 3.94% | -291,000 |
| Amazon.com Inc. AMZN | 2,632,994 | $627.5 million | 3.70% | -1,585,400 |
| Lantheus Holdings, Inc. LNTH | 5,583,479 | $619.4 million | 3.66% | no change |
| Natera Inc Com NTRA | 2,218,366 | $602.2 million | 3.55% | -989,000 |
| UnitedHealth Group Inc. UNH | 1,270,532 | $528.1 million | 3.12% | -551,174 |
| Thermo Fisher Scientific Inc. TMO | 1,049,185 | $526.0 million | 3.10% | +167,700 |
| Roivant Sciences Ltd. ROIV | 14,309,000 | $506.4 million | 2.99% | +4,634,000 |
| Aon plc AON | 1,382,562 | $458.6 million | 2.71% | -1,130,076 |
| Boston Scientific Corp. BSX | 10,521,184 | $449.0 million | 2.65% | +3,050,500 |
| Broadcom Inc. AVGO | 1,151,800 | $435.1 million | 2.57% | -627,700 |
| Microsoft Corp. MSFT | 1,112,863 | $415.1 million | 2.45% | -1,231,916 |
| Tango Therapeutics Inc. TNGX | 12,277,000 | $383.8 million | 2.26% | +3,179,589 |
| KKR & Co. Inc. KKR | 4,118,300 | $378.0 million | 2.23% | -553,500 |
| Synopsys Inc. SNPS | 829,600 | $370.1 million | 2.18% | -383,700 |
| Beam Therapeutics Inc. BEAM | 10,236,396 | $351.3 million | 2.07% | +101,700 |
| Crinetics Pharmaceuticals in CRNX | 8,989,098 | $336.4 million | 1.99% | +651,000 |
| Grail, Inc. GRAL | 4,161,584 | $284.1 million | 1.68% | +907,900 |
| Westinghouse Air Brake Technologies Corp. WAB | 894,503 | $241.2 million | 1.42% | -714,900 |
| Immunovant Inc. IMVT | 5,805,000 | $223.7 million | 1.32% | +4,259,000 |
| Twist Bioscience Corp. TWST | 2,136,400 | $219.8 million | 1.30% | +708,750 |
| Agios Pharmaceuticals Inc. AGIO | 5,917,400 | $219.6 million | 1.30% | +233,400 |
| Aramark ARMK | 3,625,731 | $206.3 million | 1.22% | -2,509,700 |
| Baidu, Inc. BIDU | 1,203,785 | $137.6 million | 0.81% | +760,000 |
| Novo Nordisk A/S NVO | 2,619,000 | $125.6 million | 0.74% | +1,837,000 |
| Acadia Healthcare Company, Inc. ACHC | 4,220,800 | $124.6 million | 0.74% | +2,484,000 |
| BrightSpring Health Services, Inc. BTSG | 1,732,800 | $120.8 million | 0.71% | +115,800 |
| AstraZeneca PLC AZN | 574,000 | $108.8 million | 0.64% | +347,501 |
| Johnson & Johnson JNJ | 408,000 | $103.6 million | 0.61% | +260,000 |
| Parabilis Medicines Inc. Com PBLS | 2,368,200 | $64.8 million | 0.38% | new |
| Novartis AG NVS | 363,000 | $56.9 million | 0.34% | new |
| Guardant Health Inc. GH | 322,200 | $48.3 million | 0.29% | +314,200 |
| Avalo Therapeutics Inc. AVTX | 2,498,000 | $46.2 million | 0.27% | +1,582,000 |
| Joyy Inc. JOYY | 699,200 | $46.1 million | 0.27% | +121,000 |
| Assembly Biosciences Inc. ASMB | 1,604,590 | $44.1 million | 0.26% | +377,000 |
| Enanta Pharmaceuticals Inc. ENTA | 2,418,202 | $35.3 million | 0.21% | -453,660 |
| Maze Therapeatics MAZE | 1,107,814 | $33.1 million | 0.20% | +734,814 |
| Merck & Co., Inc. MRK | 199,000 | $25.6 million | 0.15% | -162,000 |
| Warby Parker Inc. WRBY | 828,000 | $25.1 million | 0.15% | new |
| Perceptive Cap Solutions Cor PCSC | 2,250,000 | $24.5 million | 0.14% | no change |
| Kailera Therapeutics Inc. KLRA | 1,100,000 | $24.2 million | 0.14% | new |
| Rio Tinto plc RIO | 183,475 | $17.4 million | 0.10% | +129,675 |
| Axalta Coating Systems Ltd. AXTA | 478,000 | $16.4 million | 0.10% | new |
| Abivax SA ABVX | 122,000 | $16.3 million | 0.10% | +120,000 |
| 21VIANET Group Inc. VNET | 1,992,000 | $16.0 million | 0.09% | +1,368,653 |
| NetEase, Inc. NTES | 123,500 | $15.8 million | 0.09% | -167,719 |
| Biogen Inc. BIIB | 71,000 | $15.3 million | 0.09% | new |
| Taysha Gene Therapies Inc. TSHA | 2,250,000 | $15.3 million | 0.09% | new |
| Mobia Med Inc. MOBI | 1,128,557 | $15.1 million | 0.09% | new |
| Minerva Neurosciences Inc. NERV | 2,365,000 | $13.1 million | 0.08% | no change |
| Alamar Biosciences Inc. ALMR | 462,900 | $12.5 million | 0.07% | new |
| Alvotech ALVO | 2,859,675 | $10.6 million | 0.06% | +2,660,000 |
| Beta Bionics Inc BBNX | 595,000 | $9.3 million | 0.06% | -3,012,920 |
| Inflarx NV IFRX | 3,325,000 | $7.4 million | 0.04% | new |
| Scotts Miracle-Gro Co. SMG | 88,000 | $6.0 million | 0.04% | new |
| Waystar Holding Corp. WAY | 264,900 | $5.4 million | 0.03% | new |
| Brunswick Corp. BC | 61,000 | $5.1 million | 0.03% | new |
| Gentex Corp. GNTX | 199,000 | $5.0 million | 0.03% | new |
| IDEXX Laboratories Inc. IDXX | 9,000 | $4.7 million | 0.03% | new |
| Prime Medicine Inc. PRME | 1,240,843 | $4.6 million | 0.03% | no change |
| Commercial Metals Co. CMC | 67,000 | $4.2 million | 0.02% | new |
| Jatt II Acquisition Corp. JATT | 300,000 | $3.4 million | 0.02% | new |
| Sagimet Biosciences Inc. SGMT | 415,000 | $3.2 million | 0.02% | new |
| Summit Midstream Corporation SMC | 58,214 | $1.7 million | 0.01% | no change |
| Teva Pharmaceutical Industries Ltd. TEVA | 40,000 | $1.4 million | 0.01% | -314,000 |
| Revolution Medicines Inc. RVMDW | 120,085 | $1.1 million | 0.01% | no change |
| Cogent Biosciences Inc. COGT | 17,000 | $657,900 | 0.00% | no change |
| Aleanna Inc. ANNAW | 990,000 | $297,000 | 0.00% | no change |
| Aleanna Inc. ANNA | 78,400 | $227,360 | 0.00% | no change |
| Welltower Inc. WELL | 1,000 | $226,970 | 0.00% | -199,000 |
| Solid Power Inc. SLDPW | 405,316 | $41,423 | 0.00% | no change |
| Blue Gold Ltd BGLWW | 255,800 | $30,696 | 0.00% | -44,200 |
| Pacific Biosciences Calif in PACB | 14,200 | $23,856 | 0.00% | -120,800 |
| Geron Corp. GERN | 14,400 | $18,432 | 0.00% | -28,600 |
| Nvni Group Limited NVNIW | 375,000 | $17,550 | 0.00% | no change |
| Canopy Growth Corp. CGC | 18,000 | $17,100 | 0.00% | -12,000 |
| Rani Therapeutics Holdings-A RANI | 20,700 | $15,740 | 0.00% | -57,300 |
| Beyond Meat, Inc. BYND | 19,000 | $14,250 | 0.00% | no change |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read more
Change is shares against its 13F for the quarter before; the 104 it sold out of are in the box above.Options it reported
| Company | Option | Shares under the options | Value of those shares |
|---|---|---|---|
| SPDR S&P 500 SPY | Puts | 6,000,000 | $4.48 billion |
| iShares Trust SOXX | Puts | 130,000 | $83.3 million |
| CG Oncology Inc. CGON | Calls | 400,000 | $28.4 million |
3 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.